Madison, WI, United States of America

Debjani Phillips

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Fujifilm Cellular Dynamics, Inc.. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Debjani Phillips: Innovator in Ocular Cell Differentiation

Introduction

Debjani Phillips is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of cellular biology, particularly in the differentiation of ocular cells. Her innovative work has the potential to impact therapeutic approaches in treating ocular diseases.

Latest Patents

Debjani holds a patent titled "Method for differentiation of ocular cells and use thereof." This patent describes methods for producing a photoreceptor precursor (PRP) cell population derived from stem cells. Additionally, it outlines the therapeutic applications of these PRP cell populations, showcasing her commitment to advancing medical science.

Career Highlights

Debjani is currently employed at Fujifilm Cellular Dynamics, Inc., where she continues to push the boundaries of research in cellular differentiation. Her work is characterized by a strong focus on practical applications that can lead to significant advancements in healthcare.

Collaborations

Throughout her career, Debjani has collaborated with notable colleagues, including Brandon Shelley and Andrew Dias. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Debjani Phillips is a trailblazer in the field of ocular cell differentiation, with a patent that holds promise for therapeutic advancements. Her work at Fujifilm Cellular Dynamics, Inc. and collaborations with esteemed colleagues further highlight her impact on the scientific community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…